Andrews Research and Education Foundation
Gulf Breeze, Florida, 32561, United States
NCT Number: NCT07513142
The purpose of this study is to compare the number of days it takes for a sport participant to return to play between ultrasound guided intramuscular corticosteroid injections and platelet-poor plasma (PPP) injections for thigh muscle injuries.
Interested in participating?
Request Info15 year–30 year
All sexes
Interventional
Phase 4
Gulf Breeze, Florida, 32561, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Only drug in the study
Only biologic in the study
Time frame: Up to 1 year
Number of days required for a patient to resume full, unrestricted, and asymptomatic participation in sports following the injection.
Time frame: Up to 1 year
Visual Analog Scale (VAS) scores will be collected and analyzed at the following time points: immediately post-procedure, 24 hours, 2 weeks, 6 weeks, 12 weeks, and 1 year after the procedure. The Visual Analog Scale is a pain measurement to be obtained from the patient that ranges from 0 (no pain at all) to 10 (worst pain you can ever imagine).
Time frame: Pre-Injection
A secondary endpoint of this study includes characterization of the thigh injury using a modified version of the British Athletics Muscle Injury Classification (BAMIC) system.
Time frame: Up to 1 year post-injection
Comparison of peak strength between the injured and uninjured thigh using a digital handheld dynamometer at the time of return-to-play clearance
Andrews Research & Education Foundation
Other
A Single Blind, Randomized Controlled Trial Evaluating Platelet Poor Plasma Versus Corticosteroid Injections as A Control for Thigh Muscle Injuries
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07034040
Musculoskeletal, Musculoskeletal Diseases
Trondheim, Norway
View Trial DetailsNCT07679386
Behavior, Behavioral Symptoms
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05111925
Musculoskeletal Injuries
Bethesda, Maryland, United States
View Trial DetailsNCT07560319
Balance Changes, Core Muscle Weakness
Giza, Giza Governorate, Egypt
View Trial Details